About Colistimethate Sodium Injection IP 1 Million IU
Experience an exceptional solution to severe, multidrug-resistant infections with Colistimethate Sodium Injection IP 1 Million IU. Manufactured in a GMP-compliant facility and adhering to Indian Pharmacopoeia standards, this rarefied antibiotic offers superlative efficacy. Its latest formulation is available at a reduced and highly competitive price, featuring a discount for hospital procurement. The product presents as a white to off-white lyophilized powder, reconstituted before use, and is strictly for intravenous administration or, as advised, for inhalation. Ensure optimal patient outcomes with its robust antibacterial power under trusted medical supervision.
Precise Administration for Intensive Care Needs
Colistimethate Sodium Injection IP 1 Million IU is reserved for use by qualified healthcare professionals in intensive care, hospital, and ICU environments. The site of application is mainly intravenous, ensuring rapid and targeted antibiotic delivery. This potent material is supplied as a lyophilized powder, uniquely reconstituted with sterile water immediately before use. Strict dosing guidelines and prescription-only distribution guarantee both safety and efficacy in managing severe bacterial threats.
Expansive Market Reach and Competitive Pricing
This product caters to an extensive market value across both domestic and international regions. Shipped from India via leading FOB ports, it is available to buyers at the lowest price threshold, amplifying accessibility worldwide. Major export markets include Asia, Africa, and the Middle East, while within India, hospital networks remain the primary beneficiaries. The focus on cost efficiency and reliable supply underscores its prominence in the antibiotic sector.
FAQ's of Colistimethate Sodium Injection IP 1 Million IU:
Q: How is Colistimethate Sodium Injection IP 1 Million IU administered?
A: This medication is administered intravenously and should only be given by qualified healthcare professionals in a hospital or ICU setting. In some situations, and as per medical advice, it may be used for inhalation therapy.
Q: What are the main benefits of using Colistimethate Sodium Injection IP 1 Million IU?
A: The injection delivers superlative effectiveness against severe infections, especially those caused by multidrug-resistant Gram-negative bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii, where other antibiotics may fail.
Q: When should Colistimethate Sodium Injection IP 1 Million IU be considered for therapy?
A: It should be considered in cases requiring rarefied antibacterial treatment, particularly for hospital-acquired infections in critical care settings where susceptible strains are identified, and other antibiotics are ineffective.
Q: What is the reconstitution process for this injection?
A: Before administration, reconstitute the lyophilized powder with the specified volume of sterile water for injection. The solution should be prepared fresh and used promptly as per the instructions provided in the information leaflet.
Q: Are there any specific usage warnings associated with this product?
A: Yes, Colistimethate Sodium Injection IP 1 Million IU is for hospital use only and must be prescribed and administered by healthcare professionals to avoid serious side effects such as nephrotoxicity and neurotoxicity, particularly in sensitive or pediatric patient groups.